CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to TAK

TAK-536CCB + Hydrochlorothiazide

Phase 3
TAKEDA PHARMACEUTICAL CO LTD (TAK)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Grade I or II Essential Hypertension

View Full Landscape
Drug Information

Target Indication

Grade I or II Essential Hypertension

Clinical Trial

NCT02072330

Last updated: 11/5/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.